From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

The SP Angel Skinbiotherapeutics scandal – it gets far worse for the disgraced broker

By Tom Winnifrith, The Sheriff of AIM | Monday 1 June 2020


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Yesterday I explained how Optibiotix (OPTI) has sold 4.5 million shares in Skinbiotherapeutics (SBTX)  on Friday, a trade yet to be announced but where the buyer is clearly already selling. But this scandal is, I believe far, far bigger and should be enough to see SP Angel cold shouldered by the AIM Community.

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

Bear

Banking Déjà vu

Monday »

Bearcast

Tom Winnifrith Bearcast: PILOW talk

 

ROO

The comedy continues at Deliveroo

 

Professor

A few thoughts on retirement

Tuesday »

SUPR

Buy Supermarket Income REIT

 

Bull

Tom Winnifrith podcast share tip

Saturday »

RIO

Rio Tinto – 2022 results, how ‘resilient’?